Home » Newsletters » BioWorld Science

BioWorld Science

March 8, 2012

View Archived Issues

Novel kinase inhibitors patented

Fatty acid blocks HIV-1 infection in ex vivo cervical tissue model

HCV NS3 resistance variants detected after 7-day MK-5172 course

Strategic alliance aims to develop and commercialize new vaccines

Telormedix receives funding to develop Toll-like receptor 7 modulators

Abbott reports novel inhibitors of GlyT1

New sodium/glucose cotransporter 2 inhibitors developed in China

Roche discovers new HSL inhibitors

Scientists in Brazil identify new phosphodiesterase 5 inhibitors

Novel tablet for type 2 diabetes available in U.S. pharmacies

Horizon Pharma and Mundipharma amend commercialization agreement

Plant-derived lactic acid bacteria may help combat obesity

New anti-infectives designed at Merck & Co.

French company presents novel inhibitors of TNF-alpha

Antigen-specific MS therapy in phase I development

Mersana partners to develop novel antibody-drug conjugates

Courtagen and Avaxia join forces to create new assay

Sosei commences Japanese phase I study of antifungal

Exonhit receives E.U. grant for consortium work on predictive biomarkers

NME improves cognition in schizophrenia model

Alexza and Ferrer amend commercial partnership for Adasuve

ReGenx and Asklepios establish agreement for hemophilia A

Feraheme shows noninferiority to intravenous iron sucrose in iron deficiency anemia

KBP BioSciences reports new mineralocorticoid receptor antagonists

New diacylglycerol O-acyltransferase 1 inhibitors reported by Merck & Co.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...